Charles River Laboratories Quick Ratio 2010-2025 | CRL

Historical quick ratio values for Charles River Laboratories (CRL) over the last 10 years.
Charles River Laboratories Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2025-03-31 $1.22B $1.05B 1.16
2024-12-31 $1.13B $0.99B 1.13
2024-09-30 $1.16B $1.01B 1.15
2024-06-30 $1.15B $0.95B 1.21
2024-03-31 $1.31B $0.96B 1.37
2023-12-31 $1.23B $1.06B 1.16
2023-09-30 $1.15B $0.99B 1.16
2023-06-30 $1.22B $1.01B 1.21
2023-03-31 $1.19B $0.98B 1.21
2022-12-31 $1.18B $1.09B 1.08
2022-09-30 $1.15B $1.01B 1.14
2022-06-30 $1.14B $1.05B 1.08
2022-03-31 $1.11B $0.99B 1.12
2021-12-31 $1.08B $1.03B 1.04
2021-09-30 $1.20B $0.98B 1.22
2021-06-30 $1.07B $0.93B 1.16
2021-03-31 $1.23B $0.80B 1.53
2020-12-31 $1.02B $0.84B 1.21
2020-09-30 $0.96B $0.79B 1.22
2020-06-30 $1.07B $0.73B 1.47
2020-03-31 $1.05B $0.69B 1.51
2019-12-31 $0.86B $0.71B 1.21
2019-09-30 $0.82B $0.68B 1.20
2019-06-30 $0.88B $0.64B 1.38
2019-03-31 $0.74B $0.53B 1.39
2018-12-31 $0.77B $0.56B 1.38
2018-09-30 $0.71B $0.54B 1.32
2018-06-30 $0.77B $0.52B 1.48
2018-03-31 $0.72B $0.41B 1.78
2017-12-31 $0.71B $0.46B 1.54
2017-09-30 $0.68B $0.42B 1.62
2017-06-30 $0.63B $0.42B 1.49
2017-03-31 $0.60B $0.38B 1.57
2016-12-31 $0.56B $0.43B 1.31
2016-09-30 $0.56B $0.41B 1.35
2016-06-30 $0.60B $0.41B 1.46
2016-03-31 $0.54B $0.31B 1.74
2015-12-31 $0.47B $0.31B 1.49
2015-09-30 $0.48B $0.31B 1.53
2015-06-30 $0.54B $0.28B 1.95
2015-03-31 $0.53B $0.27B 1.95
2014-12-31 $0.49B $0.30B 1.66
2014-09-30 $0.51B $0.28B 1.81
2014-06-30 $0.50B $0.27B 1.84
2014-03-31 $0.50B $0.24B 2.09
2013-12-31 $0.46B $0.25B 1.88
2013-09-30 $0.46B $0.24B 1.96
2013-06-30 $0.43B $0.23B 1.91
2013-03-31 $0.41B $0.33B 1.23
2012-12-31 $0.40B $0.34B 1.16
2012-09-30 $0.36B $0.33B 1.12
2012-06-30 $0.36B $0.33B 1.10
2012-03-31 $0.35B $0.22B 1.55
2011-12-31 $0.33B $0.22B 1.54
2011-09-30 $0.36B $0.22B 1.62
2011-06-30 $0.45B $0.28B 1.62
2011-03-31 $0.46B $0.31B 1.50
2010-12-31 $0.45B $0.26B 1.74
2010-09-30 $0.43B $0.24B 1.80
2010-06-30 $0.51B $0.25B 2.08
2010-03-31 $0.52B $0.25B 2.09
2009-12-31 $0.49B $0.25B 1.97
2009-09-30 $0.47B $0.25B 1.83
2009-06-30 $0.47B $0.27B 1.76
2009-03-31 $0.48B $0.28B 1.73
Sector Industry Market Cap Revenue
Medical Medical Services $7.460B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.784B 27.53
Elevance Health (ELV) United States $87.260B 11.26
CVS Health (CVS) United States $83.934B 10.43
Cencora (COR) United States $57.186B 19.90
Natera (NTRA) United States $22.441B 0.00
DiDi Global (DIDIY) China $22.121B 23.50
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.853B 13.61
ICON (ICLR) Ireland $11.879B 11.04
CochLear (CHEOY) Australia $11.671B 0.00
Revvity (RVTY) United States $11.280B 19.41
Doximity (DOCS) United States $10.697B 49.52
Viatris (VTRS) United States $10.669B 3.67
Avantor (AVTR) United States $9.227B 13.41
HealthEquity (HQY) United States $8.993B 39.39
Medpace Holdings (MEDP) United States $8.737B 23.21
Sonic Healthcare (SKHHY) Australia $8.503B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.400B 25.92
BrightSpring Health Services (BTSG) United States $3.797B 34.84
Sotera Health (SHC) United States $3.335B 18.95
Alignment Healthcare (ALHC) United States $2.983B 0.00
Surgery Partners (SGRY) United States $2.961B 38.50
Concentras Parent (CON) United States $2.793B 16.14
Organon (OGN) United States $2.618B 2.78
Ardent Health (ARDT) United States $1.938B 8.26
GeneDx Holdings (WGS) United States $1.894B 72.93
Premier (PINC) United States $1.855B 14.08
Progyny (PGNY) United States $1.847B 40.66
PACS (PACS) United States $1.614B 0.00
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.258B 0.00
Pediatrix Medical (MD) United States $1.224B 9.31
Establishment Labs Holdings (ESTA) $1.073B 0.00
CareDx (CDNA) United States $1.048B 16.37
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.828B 7.75
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.694B 10.51
Embecta (EMBC) United States $0.587B 3.95
LifeMD (LFMD) United States $0.577B 0.00
Enhabit (EHAB) United States $0.505B 41.54
InnovAge Holding (INNV) United States $0.498B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Sonida Senior Living (SNDA) United States $0.467B 0.00
SBC Medicals (SBC) United States $0.464B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Performant Healthcare (PHLT) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.197B 0.00
DocGo (DCGO) United States $0.154B 25.17
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.111B 0.00
KindlyMD (NAKA) United States $0.102B 0.00
So-Young (SY) China $0.095B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
OncoCyte (OCX) United States $0.077B 0.00
Sera Prognostics (SERA) United States $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.048B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00